Seeking Alpha

St. Jude Medical (STJ +1%) says it's published positive results in an online journal from its...

St. Jude Medical (STJ +1%) says it's published positive results in an online journal from its first large-scale study of peripheral nerve stimulation of the occipital nerves in patients suffering from chronic migraine. The study, which was conducted at 15 U.S. medical centers, demonstrated a significant reduction in pain, headache days and migraine-related disability in patients who, on average, suffered from headache about 21 days per month, and received peripheral nerve stimulation therapy.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs